Maternal obesity depresses essential fatty acid transport in the placenta

孕妇肥胖会抑制胎盘中必需脂肪酸的转运

基本信息

  • 批准号:
    8847576
  • 负责人:
  • 金额:
    $ 23.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-05-01 至 2017-04-30
  • 项目状态:
    已结题

项目摘要

Project Abstract The candidate's five-year career goal is to become an independent investigator in the areas of maternal nutrition and placental nutrient transport and metabolism. Her long-term career objective is to build a strong translational research program, utilizing appropriate animal models and human investigations to study the effect of maternal pre-pregnancy nutrition on placental growth and function, neonatal health, and the offspring's risk of future cardiovascular disease. It is becoming increasingly clear that the placenta plays a key role in the origin of adverse fetal outcomes resulting from maternal over- or under-nutrition. In keeping with this view, the placenta is an important element in the origins of adult chronic disease. The candidate has a strong scientific background in molecular biology, immunohistochemistry, primary cell culture and small and large animal surgery. She has gained expertise in fetal physiology (especially of the cardiovascular system) and is well-versed in the literature surrounding the developmental origins of health and cardiovascular disease. Additional training is required however before she can achieve her career goal of becoming an independent investigator in maternal-fetal health. The proposed training program has been designed to provide: 1) training in placental physiology and research methodologies, 2) experience in nutritional science and research methodologies and 3) in-depth training in human investigation. The Oregon Health and Science University is an ideal environment for this training. It offers its strong reputation as a leading biomedical research and training institution; the Heart Research Center is internationally recognized for its work in fetal physiology and the developmental origins of health and disease; the Oregon National Primate Research Center is internationally recognized for its translational research in pregnancy and the Oregon Clinical and Translational Research Institute is dedicated to the development of successful trainees and young investigators in translational and clinical research. One in five women who deliver in the United States is obese (body mass index (BMI) of >30 kg/m2). This condition is associated with both short- and long-term adverse consequences for mother and her baby. Such babies are at risk for developing chronic diseases including adult-onset coronary heart disease and the metabolic syndrome. Our preliminary data show that male offspring of overweight and obese mothers have lower levels of docosaehexanoic acid - a long chain polyunsaturated (LC-PUFA) derivative of essential fatty acids - than female offspring, while no differences in LC-PUFA levels exist between male and female offspring of lean women. Such deficiencies lead to neurological and vascular pathologies in the newborn. All of the essential LC-PUFA that are acquired by the fetus are actively transported across the placental barrier. The effect of maternal obesity on placental delivery of LC-PUFA to the fetus is unknown. Due to their rapid growth in utero, boys invest less in placental growth than girls and are at a greater risk of undernourishment and poor outcomes in response to stressful conditions. Maternal obesity exposes the placental-fetal unit to pro-inflammatory molecules. Inflammatory cytokines inhibit fatty acid uptake in the liver, muscle and heart. The effect of inflammatory cytokines on placental transport is not known. It is also unknown whether male fetuses and their placentas are more sensitive than females to maternal obesity and inflammation. The overall goal of this proposal is to determine the degree to which maternal obesity alters gender-specific fatty acid transport in the placenta. Studies will be conducted in our non-human primate model of maternal obesity from which we will establish the relationship between obesity and 3rd trimester placental fatty acid transport in vivo using stable isotope-labeled fatty acid tracers. Complementary studies in women will determine the degree to which maternal BMI and fetal sex alter placental lipid uptake. The roles of inflammatory cytokines in altering fatty acid uptake kinetics will be determined in placental tissue isolated from lean women with male or female offspring. These translational studies will determine the effect of maternal obesity, fetal sex and inflammatory cytokines on placental fat transport in a human population. Upon completion of the proposed studies, we will have determined 1) the degree to which maternal obesity alters uptake and transport of LC-PUFA in the late gestation non-human primate placenta, 2) the effect of fetal gender on placental LC-PUFA uptake in women at term and 3) mechanisms by which inflammatory cytokines suppress placental fatty acid uptake in vitro.
项目摘要 候选人的五年职业目标是成为孕产妇营养领域的独立研究者 以及胎盘营养物质的运输和代谢。她的长期职业目标是建立强大的翻译团队 研究计划,利用适当的动物模型和人体调查来研究母体的影响 孕前营养对胎盘生长和功能、新生儿健康以及后代未来风险的影响 心血管疾病。越来越清楚的是,胎盘在胎儿的起源中起着关键作用。 母亲营养过剩或营养不足导致胎儿不良结局。根据这一观点,胎盘是 成人慢性疾病起源的一个重要因素。 候选人在分子生物学、免疫组织化学、初级 细胞培养和小型和大型动物手术。她获得了胎儿生理学方面的专业知识(尤其是胎儿生理学) 心血管系统),并且精通有关健康和发展起源的文献 心血管疾病。然而,在她实现职业目标之前,还需要接受额外的培训 成为母婴健康领域的独立研究者。拟议的培训计划已 旨在提供:1)胎盘生理学和研究方法方面的培训,2)营养方面的经验 科学和研究方法;3) 人类调查的深入培训。俄勒冈州健康与 科学大学是这种培训的理想环境。它作为领先的生物医学领域享有盛誉 研究和培训机构;心脏研究中心因其在胎儿方面的工作而获得国际认可 生理学以及健康和疾病的发育起源;俄勒冈国家灵长类动物研究中心 因其妊娠转化研究以及俄勒冈州临床和转化研究而获得国际认可 研究所致力于培养成功的实习生和年轻的研究人员 转化和临床研究。 在美国,五分之一的分娩女性患有肥胖症(体重指数 (BMI) > 30 kg/m2)。这 这种情况会对母亲和婴儿造成短期和长期的不良后果。这样的 婴儿有患慢性疾病的风险,包括成人发病的冠心病和 代谢综合征。我们的初步数据显示,超重和肥胖母亲的男性后代的死亡率较低 二十二碳六烯酸(一种必需脂肪酸的长链多不饱和 (LC-PUFA) 衍生物)的含量 女性后代的 LC-PUFA 水平不存在瘦女性的男性和女性后代之间的差异。这样的 缺陷会导致新生儿出现神经和血管病变。所有必需的 LC-PUFA 胎儿获得的物质主动转运穿过胎盘屏障。产妇肥胖对产妇的影响 胎盘向胎儿输送 LC-PUFA 的情况尚不清楚。由于男孩在子宫内生长迅速,对胎盘的投资较少 生长发育低于女孩,并且因应对压力条件而面临更大的营养不良和不良后果的风险。 母亲肥胖会使胎盘-胎儿单位暴露于促炎分子。炎症细胞因子抑制脂肪 肝脏、肌肉和心脏的酸吸收。炎症细胞因子对胎盘转运的影响尚不清楚。这是 还不清楚男性胎儿及其胎盘是否比女性对母亲肥胖更敏感 炎。该提案的总体目标是确定孕产妇肥胖改变的程度 胎盘中性别特异性脂肪酸运输。 研究将在我们的非人类灵长类动物母亲肥胖模型中进行,我们将从中 使用稳定的方法建立肥胖与妊娠第三期胎盘脂肪酸体内转运之间的关系 同位素标记的脂肪酸示踪剂。对女性的补充研究将确定母亲的影响程度 BMI 和胎儿性别改变胎盘脂质摄取。炎症细胞因子在改变脂肪酸摄取中的作用 将在从具有男性或女性后代的瘦女性身上分离的胎盘组织中测定动力学。这些 转化研究将确定母亲肥胖、胎儿性别和炎症细胞因子对 人群中胎盘脂肪的运输。 完成拟议的研究后,我们将确定 1) 母亲的程度 肥胖改变妊娠晚期非人灵长类胎盘中 LC-PUFA 的摄取和转运,2) 胎儿性别对足月妇女胎盘 LC-PUFA 摄取的影响以及 3) 机制 炎症细胞因子在体外抑制胎盘脂肪酸的摄取。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fatty acid transporter expression and regulation is impaired in placental macrovascular endothelial cells in obese women.
肥胖女性胎盘大血管内皮细胞中脂肪酸转运蛋白的表达和调节受损。
  • DOI:
  • 发表时间:
    2019-03
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yang, Xiaohua;Glazebrook, Patricia;Ranasinghe, Geraldine C;Haghiac, Maricela;Calabuig;Minium, Judi;O'Tierney
  • 通讯作者:
    O'Tierney
Neonatal fatty acid profiles are correlated with infant growth measures at 6 months.
新生儿脂肪酸谱与 6 个月时婴儿的生长指标相关。
  • DOI:
  • 发表时间:
    2017-08
  • 期刊:
  • 影响因子:
    0
  • 作者:
    O'Tierney;Davina, D;Gillingham, M;Barker, D J P;Morris, C;Thornburg, K L
  • 通讯作者:
    Thornburg, K L
Maternal obesity is not associated with placental lipid accumulation in women with high omega-3 fatty acid levels.
对于 omega-3 脂肪酸水平较高的女性,孕妇肥胖与胎盘脂质积累无关。
  • DOI:
  • 发表时间:
    2018-09
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Alvarado, Fernanda L;Calabuig;Haghiac, Maricela;Puchowicz, Michelle;Tsai, Pai;O'Tierney
  • 通讯作者:
    O'Tierney
Let's Talk About Sex: Placentas' Central Role in Sexually Dimorphic Responses to the Maternal Milieu.
让我们谈谈性:胎盘在对母体环境的性二态反应中的核心作用。
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    O'Tierney
  • 通讯作者:
    O'Tierney
Placental oleic acid uptake is lower in male offspring of obese women.
肥胖女性的男性后代的胎盘油酸摄取量较低。
  • DOI:
    10.1016/j.placenta.2013.03.009
  • 发表时间:
    2013-06
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Brass, E.;Hanson, E.;O'Tierney-Ginn, P. F.
  • 通讯作者:
    O'Tierney-Ginn, P. F.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Perrie F O'Tierney-Ginn其他文献

Perrie F O'Tierney-Ginn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Perrie F O'Tierney-Ginn', 18)}}的其他基金

Administrative Supplement to Placental miRNA profiles associated with maternal insulin resistance and fetal adiposity: maternal-placental crosstalk
与母体胰岛素抵抗和胎儿肥胖相关的胎盘 miRNA 谱的行政补充:母体-胎盘串扰
  • 批准号:
    9911807
  • 财政年份:
    2019
  • 资助金额:
    $ 23.46万
  • 项目类别:
Placental lipid metabolism impacts fetal adiposity and is programmed by the maternal metabolic milieu in early pregnancy
胎盘脂质代谢影响胎儿肥胖,并受妊娠早期母体代谢环境影响
  • 批准号:
    10201689
  • 财政年份:
    2017
  • 资助金额:
    $ 23.46万
  • 项目类别:
Placental lipid metabolism impacts fetal adiposity and is programmed by the maternal metabolic milieu in early pregnancy
胎盘脂质代谢影响胎儿肥胖,并受妊娠早期母体代谢环境影响
  • 批准号:
    9397888
  • 财政年份:
    2017
  • 资助金额:
    $ 23.46万
  • 项目类别:
Maternal Metabolic Markers of infant Adiposity (MAMMA) Study supplement)
婴儿肥胖的母体代谢标志物 (MAMMA) 研究补充品)
  • 批准号:
    10591672
  • 财政年份:
    2017
  • 资助金额:
    $ 23.46万
  • 项目类别:
Maternal obesity depresses essential fatty acid transport in the placenta
孕妇肥胖会抑制胎盘中必需脂肪酸的转运
  • 批准号:
    8643321
  • 财政年份:
    2013
  • 资助金额:
    $ 23.46万
  • 项目类别:
Maternal obesity depresses essential fatty acid transport in the placenta
孕妇肥胖会抑制胎盘中必需脂肪酸的转运
  • 批准号:
    8706701
  • 财政年份:
    2013
  • 资助金额:
    $ 23.46万
  • 项目类别:
Maternal obesity depresses essential fatty acid transport in the placenta
孕妇肥胖会抑制胎盘中必需脂肪酸的转运
  • 批准号:
    8111040
  • 财政年份:
    2011
  • 资助金额:
    $ 23.46万
  • 项目类别:
Maternal obesity depresses essential fatty acid transport in the placenta
孕妇肥胖会抑制胎盘中必需脂肪酸的转运
  • 批准号:
    8257957
  • 财政年份:
    2011
  • 资助金额:
    $ 23.46万
  • 项目类别:

相似国自然基金

AMPK通过调控Smurf1的SUMO化抑制创伤性异位骨化的研究
  • 批准号:
    31900852
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
血管微环境中内皮细胞AMPK抑制心肌纤维化的功能与机制研究
  • 批准号:
    81800273
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
基于AMPK-FXR-BSEP介导的齐墩果酸所致胆汁淤积性肝损伤作用机制研究
  • 批准号:
    81760678
  • 批准年份:
    2017
  • 资助金额:
    35.0 万元
  • 项目类别:
    地区科学基金项目
基于AMPK信号通路研究菝葜黄酮调控脂类代谢分子机制
  • 批准号:
    81760157
  • 批准年份:
    2017
  • 资助金额:
    32.0 万元
  • 项目类别:
    地区科学基金项目
AMPK通过Wnt/β-catenin信号通路调控绵羊肌内脂肪前体细胞分化的研究
  • 批准号:
    31402053
  • 批准年份:
    2014
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Glyoxalase 1 and its Role in Metabolic Syndrome
乙二醛酶 1 及其在代谢综合征中的作用
  • 批准号:
    10656054
  • 财政年份:
    2023
  • 资助金额:
    $ 23.46万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 23.46万
  • 项目类别:
Targeting ferroptosis in cancer therapy
癌症治疗中的靶向铁死亡
  • 批准号:
    10581748
  • 财政年份:
    2023
  • 资助金额:
    $ 23.46万
  • 项目类别:
Deciphering the Molecular Mechanisms by which PKA inhibits mTORC1
破译 PKA 抑制 mTORC1 的分子机制
  • 批准号:
    10365712
  • 财政年份:
    2022
  • 资助金额:
    $ 23.46万
  • 项目类别:
Use of SGLT2 inhibition to improve skeletal muscle metabolism in prediabetes
利用 SGLT2 抑制改善糖尿病前期的骨骼肌代谢
  • 批准号:
    10420977
  • 财政年份:
    2022
  • 资助金额:
    $ 23.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了